Skip to main content
. 2022 Aug 18;19(1):114–119. doi: 10.1007/s12015-022-10446-5

Fig. 3.

Fig. 3

Endothelial circulating EVs in COVID-19 patients. 3A: CD31 + CD41-, CD144+ and CD62E+ EVs levels at admission (Mann-Whitney and Fisher’s tests) 3B: Kaplan–Meier survival curves, illustrating prognostic impact of CD62E+ EVs